Ionis Pharmaceuticals (IONS) EBITDA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA, bln rub | ? | 366.0 | -172.0 | -21.0 | -561.0 | -322.8 | -329.0 | ||
Changes by years, y/y, % | -695% | -147% | -88% | +2 571% | -42% | +39.3% |
Ionis Pharmaceuticals. EBITDA US GAAP, bln rub
Ionis Pharmaceuticals. EBITDA US GAAP, changes, %
Ionis Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Ionis Pharmaceuticals (IONS) EBITDA US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
EBITDA, bln rub | ? | -59.0 | -123.0 | -1.67 | -143.9 | -60.5 | -329.0 | |
Changes by years, y/y, % | -37% | +143% | -100% | +48% | +3% | |||
Changes by quarters, q/q, % | -39% | +108% | -99% | +8 514% | -58% |